Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I (Q45752944)
scientific article published in October 1998
Language:
(P31) (Q13442814)
(P50) (Q43252014)
(P304) 1426-1432
(P407) (Q1860)
(P433) 9138
(P478) 352
(P577) Thursday, October 1, 1998
(P921) (Q269829)
(Q421862)
(Q708693)
(Q154869)
(P1104) 7
(P1433) (Q939416)
(P1476) "Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I" (language: en)
(P2093) P Marcellin
S S Lee
C Niederau
G S Minuk
G Ideo
V Bain
J Heathcote
S Zeuzem
C Trepo
J Albrecht
(P2860) (Q28249543)
(Q43595642)
(Q44746801)
(Q29614459)
(Q45884343)
(Q71650797)
(Q70955349)
(Q43039883)
(Q38016839)
(Q28318414)
(Q42980410)
(Q50588396)
(Q42986315)
(Q43040784)
(Q29620971)
(Q29614898)
(Q29619627)
(Q41598802)
(Q73483382)
(Q42981340)
(Q42985646)
other details
description scientific article published in October 1998

External Links